Source:http://linkedlifedata.com/resource/pubmed/id/11362920
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
10
|
| pubmed:dateCreated |
1995-11-15
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
X
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
1077-1824
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
9
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
9
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:11362920-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:11362920-Budgets,
pubmed-meshheading:11362920-Financing, Government,
pubmed-meshheading:11362920-National Institutes of Health (U.S.),
pubmed-meshheading:11362920-Research Support as Topic,
pubmed-meshheading:11362920-United States
|
| pubmed:year |
1995
|
| pubmed:articleTitle |
New NCI director confronts troubled agency. National Cancer Institute.
|
| pubmed:publicationType |
Newspaper Article
|